IRIS UniCatt

Agnes, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.388
EU - Europa 6.198
AS - Asia 5.952
SA - Sud America 1.090
Continente sconosciuto - Info sul continente non disponibili 228
AF - Africa 146
OC - Oceania 14
Totale 22.016
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.151
SG - Singapore 2.635
DE - Germania 2.006
CN - Cina 1.627
SE - Svezia 941
BR - Brasile 892
IT - Italia 678
UA - Ucraina 620
FR - Francia 538
VN - Vietnam 506
IE - Irlanda 301
GB - Regno Unito 300
FI - Finlandia 240
PL - Polonia 207
ID - Indonesia 177
IN - India 176
JP - Giappone 160
BD - Bangladesh 118
CA - Canada 117
HK - Hong Kong 103
TR - Turchia 102
RU - Federazione Russa 94
AR - Argentina 76
MX - Messico 66
IQ - Iraq 63
BE - Belgio 58
ZA - Sudafrica 49
KR - Corea 47
NL - Olanda 36
ES - Italia 33
IR - Iran 33
SA - Arabia Saudita 30
PK - Pakistan 28
EC - Ecuador 26
AT - Austria 25
CO - Colombia 25
VE - Venezuela 25
LT - Lituania 22
MA - Marocco 17
UZ - Uzbekistan 17
CH - Svizzera 16
KE - Kenya 16
CL - Cile 15
PH - Filippine 14
AE - Emirati Arabi Uniti 13
CI - Costa d'Avorio 13
EU - Europa 13
CZ - Repubblica Ceca 12
PY - Paraguay 12
RO - Romania 12
TH - Thailandia 12
EG - Egitto 11
TN - Tunisia 11
DZ - Algeria 10
JM - Giamaica 10
NP - Nepal 10
AU - Australia 9
AZ - Azerbaigian 9
JO - Giordania 9
PT - Portogallo 8
UY - Uruguay 8
IL - Israele 7
LV - Lettonia 7
PA - Panama 7
TW - Taiwan 7
BY - Bielorussia 6
CR - Costa Rica 6
MY - Malesia 6
PE - Perù 6
BG - Bulgaria 5
BH - Bahrain 5
DK - Danimarca 5
ET - Etiopia 5
GR - Grecia 5
HN - Honduras 5
PR - Porto Rico 5
DO - Repubblica Dominicana 4
EE - Estonia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
OM - Oman 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AO - Angola 3
CY - Cipro 3
GA - Gabon 3
GD - Grenada 3
GE - Georgia 3
KW - Kuwait 3
LB - Libano 3
PS - Palestinian Territory 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
BN - Brunei Darussalam 2
BO - Bolivia 2
BZ - Belize 2
GT - Guatemala 2
Totale 21.771
Salva come PNG Salva come JPEG
Città #
Singapore 1.324
Chandler 990
Ashburn 905
San Jose 695
Jacksonville 353
Beijing 297
Dublin 293
San Mateo 274
New York 256
Los Angeles 224
Ann Arbor 203
Nanjing 189
Ho Chi Minh City 169
Jakarta 160
Lauterbourg 157
The Dalles 152
Tokyo 143
Warsaw 142
Hanoi 135
Rome 135
Wilmington 135
Hefei 130
Boston 125
Munich 122
Woodbridge 115
Nürnberg 112
Dallas 109
Buffalo 107
Marseille 104
Frankfurt am Main 102
Chicago 99
Milan 99
Santa Clara 98
Seattle 96
Dearborn 92
Helsinki 92
Lawrence 91
Hong Kong 85
Bremen 83
Houston 82
Redwood City 81
Cattolica 80
Nanchang 70
Izmir 69
São Paulo 65
Moscow 64
Shenyang 60
Hangzhou 58
Fairfield 57
Princeton 53
Brussels 52
Lancaster 48
Zhengzhou 48
Hebei 42
University Park 39
Atlanta 38
Augusta 38
Tianjin 38
Shanghai 37
Toronto 37
Detroit 36
London 35
Council Bluffs 34
Johannesburg 33
Mountain View 33
Andover 32
Changsha 31
Nuremberg 31
Phoenix 31
Da Nang 30
Guangzhou 29
Kent 29
Belo Horizonte 28
Boardman 28
Kraków 28
Rio de Janeiro 28
Seoul 28
Paris 27
Tukwila 27
Turku 27
Baghdad 26
Kunming 26
Norwalk 26
Mexico City 23
Brooklyn 22
Dhaka 22
Pune 22
Charlotte 21
Orem 21
Curitiba 20
Jiaxing 20
Memphis 20
Montreal 20
Chengdu 19
Düsseldorf 19
Jinan 19
Mumbai 19
Denver 18
Kish 18
Cambridge 17
Totale 11.371
Salva come PNG Salva come JPEG
Nome #
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 382
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 354
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. 328
Bacterial bloodstream infections in liver transplantation: etiologic agents and antimicrobial susceptibility profiles 256
Liver Transplantation in Alcoholic Patients: Impact of an Alcohol Addiction Unit Within a Liver Transplant Center 253
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 250
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant 239
Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.- 229
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 209
Duplex Doppler in the postoperative monitoring of liver transplant recipients 208
Lumbar chemical sympathectomy in end stage of arterial disease: early and late results 192
Liver transplantation in patients with alcoholic liver disease: A retrospective study 192
Optimization of Donor-Recipient match and identification of the futile match cutoff. A national italian study on liver transplantation. 190
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 188
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 187
Importance of donor blood chemistry data (AST, serum sodium) in predicting liver transplant outcome 186
Use of an esophageal echo-Doppler device during liver transplantation: preliminary report 185
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 183
Thromboelastography does not reduce transfusion requirements in liver transplantation: A propensity score-matched study 182
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 179
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 170
Acute Liver Failure in an Adult, a Rare Complication of Alagille Syndrome: Case Report and Brief Review 167
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center 166
Enteric-coated mycophenolate sodium: one-way conversion from mycophenolate mofetil and de novo use in stable liver transplant recipients 165
Enzymatic determinations in acute rejection after liver transplantation: preliminary report on necrosis index 164
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation 163
Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match 162
Comparative evaluation of two perfusion solutions for liver preservation and transplantation. 159
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 159
Preliminary experience using N-butyl cyanoacrylate for management of bleeding after percutaneous transhepatic biliary drain placement: a technical note 158
Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantation 158
Fungal infections after liver transplantation: incidence and outcome 157
Pediatric T-tube in adult liver transplantation: Technical refinements of insertion and removal 157
Prediction of 6-month survival after liver transplantation using Cox regression. 155
Psychological risk factors for graft rejection among liver transplant recipients 155
Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation 155
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 154
Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association 154
Adipose tissue-derived mesenchymal stem cells and hepatic differentiation: old concepts and future perspectives 153
Intra-operative parathyroid hormone monitoring through central laboratory is accurate in renal secondary hyperparathyroidism. 153
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs 152
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 151
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 151
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 150
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 150
Mitochondrial liver enzymes and the ratio between mitochondrial and cytoplasmic enzymes in the differential diagnosis of acute rejection after liver transplantation 149
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 149
Orpitt: a computerized chart for intraoperative real time management of liver transplant data 147
D-MELD, a strong and accurate tool to guide donor-2-recipient matching 147
Proposal and validation of a liver graft discard score for liver transplantation from deceased donors: a multicenter Italian study 147
Is primary nonfunction still a suitable indication for liver retransplantation? 146
[Blood recovery and autotransfusion within integrated transfusion systems during liver transplantation. The authors' own experience] 145
Donor risk index and organ patient index as predictors of graft survival after liver transplantation 145
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 144
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 143
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV patients. 143
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 142
High intraoperative blood product requirements in liver transplantation: Risk factors and impact on the outcome 141
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 140
Psychological risk factors for graft rejection among liver transplant recipients 138
Model for end-stage liver disease dynamic stratification of survival benefit 138
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 137
Anidulafungin--a new therapeutic option for Candida infections in liver transplantation 137
Overextended Criteria Donors: Experience of an Italian Transplantation Center 136
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 136
Preliminary experience using N-butyl cyanoacrylate for management of bleeding after percutaneous transhepatic biliary drain placement: a technical note 135
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 135
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 134
Availability of a Web and Smartphone Application to Stratify the Risk of of Early Allograft Failure Requiring Liver Retransplantation 133
Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation 133
Migration rate using Fully-covered metal stent in anastomotic strictures after liver transplantation: Results from the BASALT Study Group 133
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 132
Role of alpha-fetoprotein in selection of patients with hepatocellular carcinoma waiting for liver transplantation: must we reconsider it? 131
Paradoxical effect of short-term protein loading on CsA-treated kidney transplant recipients 131
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 131
Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study 129
Indocyanine green clearance tests to assess liver transplantation outcomes: a systematic review 129
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 129
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center 129
Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival 128
A Case of Insulinoma Detected by 68Ga-DOTANOC PET/CT and Missed by 18F-Dihydroxyphenylalanine PET/CT 128
Results of liver transplantation for hepatitis delta disease without immunoprophylaxis 128
The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor. 127
Pregnancy After Liver Transplant: Neonatal Outcomes and Long-Term Maternal Follow-up 126
Mitochondrial/cytoplasmic enzyme ratio for the diagnosis of acute rejection after liver transplantation: sensitivity and specificity 125
Pancreatic function assessment 125
CONUT Score Predicts Early Morbidity After Liver Transplantation: A Collaborative Study 124
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 123
Lamivudine-induced muscle mitochondrial toxicity 123
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 123
Letter to the Editor: Suboptimal performance of CAR-OLT score to predict 1-year risk of cardiovascular events after liver transplantation 123
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 122
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation 121
Prediction of 6-month survival after liver transplantation using Cox regression 118
Primary difunction after liver trasplantation: donor or recipients fault? 118
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 117
Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-Analysis 117
Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients 116
Intraoperative trends of oxygen consumption and blood lactate as predictors of primary dysfunction after liver transplantation 116
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 116
Totale 15.768
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.097
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.368 0 187 28 105 71 47 10 259 62 83 199 317
2022/20232.818 323 364 260 434 183 364 149 210 311 70 120 30
2023/20241.356 55 428 39 148 58 176 89 43 16 49 128 127
2024/20252.991 45 79 237 114 277 80 80 146 472 307 653 501
2025/20267.308 1.192 184 436 748 1.217 345 1.287 324 436 523 283 333
2026/2027639 518 121 0 0 0 0 0 0 0 0 0 0
Totale 22.016